文献速递神经肿瘤神经重症

营养状况对胶质母细胞瘤术后预后的影响

The Prognostic Impact of Nutritional Status on Postoperative Outcomes in Glioblastoma.
PubMed 文献 · World Neurosurg · 2020-11-13

该回顾性研究纳入242例接受手术的胶质母细胞瘤患者,使用白蛋白、AGR、NRI和PNI四种营养指数评估营养状况,发现低白蛋白、中度和中重度NRI及低PNI与术后生存期缩短独立相关,PNI模型预测性能最佳。

要点

  • 低白蛋白、低PNI及中度以上NRI是胶质母细胞瘤术后生存不良的独立预测因素。
  • PNI在四种营养指数中对术后生存的预测模型最优。
  • 营养状况是可干预的脑肿瘤管理环节,应予重视。

核心结论

  • 营养状况可预测胶质母细胞瘤患者的术后生存期,PNI可能是评估营养状况的最佳模型。

研究设计与样本

  • 回顾性纳入2007年至2019年在本机构接受手术的胶质母细胞瘤患者242例,使用白蛋白、AGR、NRI和PNI四种营养指数评估营养状况。

主要发现

  • 患者平均年龄57.6岁,男性占64%,KPS平均77.6,mFI-5平均0.59,白蛋白平均4.2 g/dL,AGR平均1.9,NRI平均105.6,PNI平均47.4。
  • 初次手术和再次手术后的中位生存期分别为12.7个月和7.8个月。
  • 多变量分析显示,低白蛋白水平(HR 2.09,95%CI 1.52-2.89,P<0.001)、轻度NRI(HR 1.61,95%CI 1.04-2.49,P=0.032)、中/重度NRI(HR 2.51,95%CI 1.64-3.85,P<0.001)和低PNI(HR 2.51,95%CI 1.78-3.53,P<0.001)预测术后生存期缩短,而低AGR(HR 1.17,95%CI 0.89-1.54,P=0.270)无显著预测作用。
  • PNI的赤池信息准则值最低。

关键数值与推荐

  • 各营养指数的最佳截断值通过最大选择秩统计量和既往既定标准确定。

临床怎么用

  • 对于胶质母细胞瘤手术患者,应关注营养状况,低白蛋白、低PNI或中重度NRI提示预后较差,PNI可作为首选的营养评估工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The clinical impact and optimal method of assessing nutritional status (NS) have not been rigorously examined in glioblastoma. We investigated the relationship between NS and postoperative survival (PS) in glioblastoma using 4 nutritional indices and identified which index best modeled PS. METHODS: NS was retrospectively assessed for patients with glioblastoma undergoing surgery at our institution from 2007 to 2019 using the albumin level, albumin/globulin ratio (AGR), nutritional risk index (NRI), and prognostic nutritional index (PNI). Optimal cut points for each index were identified using maximally selected rank statistics and previously established criteria. The predictive value of each index on PS was determined using Cox proportional hazards models adjusted for prognostic variables. The best-performing model was identified using the Akaike Information Criterion. RESULTS: Our analysis included 242 patients (64% male) with a mean age of 57.6 years, Karnofsky Performance Status of 77.6, 5-factor modified frailty index of 0.59, albumin level of 4.2 g/dL, AGR of 1.9, NRI of 105.6, and PNI of 47.4. Median PS after index and repeat surgery was 12.7 and 7.8 months, respectively. On multivariable analysis, low albumin level (hazard ratio [HR], 2.09; 95% confidence interval [CI], 1.52-2.89; P < 0.001), mild NRI (HR, 1.61; 95% CI, 1.04-2.49; P = 0.032), moderate/severe NRI (HR, 2.51; 95% CI, 1.64-3.85; P < 0.001), and low PNI (HR, 2.51; 95% CI, 1.78-3.53; P < 0.001), but not low AGR (HR, 1.17; 95% CI, 0.89-1.54; P = 0.270), predicted decreased PS. PNI had the lowest Akaike Information Criterion. CONCLUSIONS: NS predicts PS in glioblastoma. PNI may provide the best model for assessing NS. NS is an important modifiable aspect of brain tumor management that warrants increased attention.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Huq S, Khalafallah AM, Botros D, et al. The Prognostic Impact of Nutritional Status on Postoperative Outcomes in Glioblastoma. World Neurosurg. 2020. PMID: 33197633. doi:10.1016/j.wneu.2020.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。